project id: TCGA-CHOL; case submitter id: TCGA-W5-AA2M; selected normal wgs: true; source center: 23; state: released; analyte type: DNA; analyte type id: D; spectrophotometer method: PicoGreen; age at index: 49; days to birth: -17989; days to death: 540; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1957; year of death: 2007; age at diagnosis: 17989; ajcc pathologic m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVB; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C24.0; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Extrahepatic bile duct; synchronous malignancy: No; tissue or organ of origin: Extrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; weight: 30.0; days to collection: 2879; initial weight: 90.0; sample id: 319e93ac-350a-46d8-8bed-4424ca02be5e; sample submitter id: TCGA-W5-AA2M-01A; portion id: 6a57229a-8b0e-40bf-9ad4-dad4c40f9331; portion submitter id: TCGA-W5-AA2M-01A-11; slide id: 1d5ef56c-b323-4c6e-831e-ce6c6f5b5809; slide submitter id: TCGA-W5-AA2M-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; section location: TOP;